Endometrial Hyperplasia Clinical Trials in Michigan

Home | Studies | Endometrial Hyperplasia

Struggling With Irregular & Painful Periods?

Exploring New Possibilities for Endometrial Health

Endometrial hyperplasia is a condition characterized by the thickening of the endometrial lining of the uterus. Although it is not cancer, it may increase the risk of developing endometrial cancer. Revival Research Institute is currently conducting endometrial hyperplasia clinical trials Michigan to evaluate new investigational therapies for women diagnosed with non-atypical endometrial hyperplasia (NAEH).

Revive Research Institute is conducting Endometrial Hyperplasia Clinical Trials in Dearborn Heights, Michigan investigating possible treatments for Endometrial Hyperplasia symptoms including painful periods.

You may qualify for the Paid Endometrial Hyperplasia Clinical Trial near you if you are:

Females who are post-menarchal (aged 16 or older)
Histologically confirmed diagnosis of non-atypical endometrial hyperplasia (NAEH)
Accept either Mirena IUS or oral progestin (OP) treatment arms

*Additional criteria may apply

*Take part in paid Endometrial Hyperplasia Clinical Trials at no cost to you or your medical insurance. You will be reimbursed financially for your time and travel. In addition, all participants receive study-related care from an experienced research team.

*If you are interested in participating in the Endometrial Hyperplasia Clinical Trials in Dearborn, Michigan or would like more information, please fill out the form so we can determine if you qualify for the study and contact you. Note that this is an entirely voluntary decision.

*Who is this information for?

A Family Member

A Friend

My Patient

Please provide YOUR contact information only.

First Name

Last Name

Phone

Confirm Phone

Best time to call?

Morning

Middle of the day

Evening

state

How did you hear about us?

Comments

*User Agreement

By Signing up, I agree to be contacted via calls and SMS.

For more info, please visit Privacy Policy.

About Endometrial Hyperplasia Clinical Trials in Michigan

This endometrial hyperplasia clinical trials Michigan is designed as a Phase III comparative study. It investigates the effectiveness of hormonal treatments to reverse or manage NAEH and potentially prevent the progression to endometrial cancer.

Participants will be monitored closely by a team of experienced healthcare providers. Study procedures include regular gynecological assessments, cervical smears, breast imaging (as required), and endometrial sampling to track response to treatment. All study-related care, including medications and exams, is provided at no cost.

Participation is voluntary, and you may withdraw at any time.

*There is no cost to you, your private medical insurance, or the public health insurance plan for study procedures. The study-related procedures, and visits will be provided at no charge throughout the duration of the study.

What You Can Expect

Has your menstrual health been affected by heavy bleeding or irregular periods?
If you are suffering from symptoms associated with endometrial hyperplasia and want to participate in a paid Endometrial Hyperplasia Clinical Trial, please reach out to us by filling in the form above. One of our study team representatives will contact you to see if you are eligible for this study (pre-screening).

Someone from the research team will ask you to sign an Informed Consent Form (ICF) if you meet the study criteria during the pre-screening process. Once you sign the ICF, we will invite you for a screening visit to our clinical site; this will be an initial visit. After that, you will undergo a series of health-related questions and tests to confirm your eligibility as a participant.

Once you receive confirmation of eligibility, you will formally be a part of the Endometrial Hyperplasia Clinical Trial. You will receive all the information about the research study you might enroll in during the ICF process. We encourage you to ask as many questions as you would like before deciding to participate.

*All study-related care is provided free of cost. Complete physical examination and other study-related assessments will be done by expert physicians and health care experts.

Length of Study

Approx. 10 months

No. of Study Visits

Approx. 5 visits

Location

Michigan

About Endometrial Hyperplasia Symptoms

Endometrial hyperplasia occurs when the uterine lining becomes too thick due to an imbalance of estrogen and progesterone. This condition often leads to symptoms such as abnormal uterine bleeding, spotting between periods, or heavy menstrual flow. If left untreated, some forms of hyperplasia may progress to endometrial cancer. As a result, women may experience a wide range of physical and emotional endometrial hyperplasia symptoms.

Endometrial Hyperplasia Symptoms
Abnormal uterine bleeding
Postmenopausal bleeding
Spotting or discharge between periods
Menstrual irregularities
Pelvic pain or discomfort
Fatigue

Frequently Asked Questions (FAQs)

1. What is Endometrial Hyperplasia?

Endometrial hyperplasia is a condition in which the lining of the uterus becomes abnormally thick. It often results from an imbalance of estrogen and progesterone and may cause irregular menstrual cycles or bleeding.

2. Who is eligible for this clinical trial?

The trial is open to women aged 16 and above who have been diagnosed with non-atypical endometrial hyperplasia. Other criteria include willingness to use either IUS or oral progestin and meeting specific cervical and breast health requirements.

3. What is the difference between Mirena and oral progestin?

Mirena is a hormonal intrauterine system placed inside the uterus to release progestin locally. Oral progestin is taken in pill form. Both aim to regulate the endometrial lining and prevent overgrowth.

4. Are there any costs involved?

No, participation in the endometrial hyperplasia clinical trials Michigan is completely free. All tests, medications, and consultations are covered by the sponsor.

5. How is this study related to endometrial cancer?

This trial focuses on non-atypical endometrial hyperplasia, which can be a precursor to cancer. Studying effective treatments for NAEH may help reduce the risk of progression to endometrial cancer, contributing to endometrial cancer clinical trials Michigan efforts.

Endometrial Hyperplasia Clinical Trials Michigan